|staar surgical stock||0.29||0.9||572||89|
|staar surgical stock price||1.33||0.8||3010||79|
|staar surgical stock price today||0.33||0.8||1400||68|
|staar surgical stock news||0.01||0.2||2413||98|
|staar surgical stock chart||0.07||0.6||483||37|
|staar surgical stock quote||1.24||0.4||6251||55|
|staar surgical stock history||0.87||1||3546||2|
|stock staar surgical company||1.56||1||578||44|
5 Wall Street analysts have issued 1 year target prices for STAAR Surgical's shares. Their forecasts range from $150.00 to $150.00. On average, they anticipate STAAR Surgical's stock price to reach $150.00 in the next twelve months. This suggests that the stock has a possible downside of 4.7%.How did STAAR surgical (STAA) perform in Q2?
STAAR Surgical Company (NASDAQ: STAA) Q2 sales increased 77% Y/Y to $62.4 million and up 23% on a sequential basis, beating the consensus of $52.56 million. The growth was attributable to global ICL sal... Staar Surgical (STAA) delivered earnings and revenue surprises of 237.50% and 17.09%, respectively, for the quarter ended June 2021.How has covid-19 affected STAA surgical stock?
STAAR Surgical's stock was trading at $28.01 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, STAA stock has increased by 462.1% and is now trading at $157.45. View which stocks have been most impacted by COVID-19.Is the selling pressure coming to an end for STAA?
STAAR Surgical (STAA) has been struggling lately, but the selling pressure may be coming to an end soon. LAKE FOREST, Calif.-- (BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announ...